1. Industry Background and Current Situation Analysis
1.1 Overview of DeSci
From the workshop-style production relying on human collaboration during the handicraft era, to the factory system restructured by steam power in the mechanization era; from the standardized economies of scale spawned by assembly lines in the electrification era to the global supply chain revolution triggered by computer technology in the information age; to the current AI era with algorithm-driven intelligent decision-making networks—each technological revolution reshapes the organizational form of production factors. The emergence of blockchain technology has achieved 'trust automation' for the first time through mathematical protocols, enabling the on-chain confirmation of intellectual property, decentralized circulation of data assets, and value distribution dominated by smart contracts. By storing knowledge and data on-chain, DeSci (Decentralized Science) is leading a disruptive technological paradigm revolution, attempting to liberate science from closed ivory towers, and the underlying logic of human production relationships is undergoing a paradigmatic leap.
Previously, the DeSci sector experienced a wave of enthusiasm in the secondary market, which has now gradually cooled. In the previous wave, it was a financial manifestation of expectations, appearing in the form of Memecoins, but we cannot deny the DeSci sector because of this. Rather, we should conduct in-depth analysis at this time to understand the true value behind DeSci and its future impact on the shift in technological paradigms.
Hard technology paradigm shift
The core concept of DeSci includes the following key aspects:
Incentive mechanisms: Restructuring the distribution of research value
DeSci fundamentally changes the value distribution model in traditional research by introducing a blockchain-based incentive system. Researchers can gain academic recognition and economic returns through token economics, NFT papers, or reputation systems, which not only incentivizes broad sharing of knowledge but also provides new pathways for the monetization of research achievements.
Decentralization: Restructuring the Power Structure of Research
In traditional research models, funding distribution and results review are often controlled by a few centralized institutions, leading to uneven resource distribution and restricted innovation. DeSci democratizes resource distribution by devolving power to the research community through community-driven models such as DAOs (Decentralized Autonomous Organizations).
Lowering the threshold for scientific research: Promoting the democratization of science
DeSci significantly lowers the participation threshold for scientific research through decentralized infrastructure (such as open data platforms, distributed computing resources, etc.). Whether researchers from developing countries, independent scientists, or citizen scientists, all can equally access global research resources and contribute.
Data transparency: Rebuilding the academic trust system
The traceability characteristics of blockchain technology provide technical guarantees for the transparency and verifiability of research data. Every step, from experimental design to data collection and publication, can be recorded and publicly verified. This effectively curbs academic misconduct and enhances public trust in scientific research.
The essence of DeSci is a return to the nature of science—science should be a common wealth of all humanity, not an exclusive domain of a few institutions or elites. In the traditional research model, the creation and dissemination of knowledge are controlled by multiple intermediaries, causing science to gradually deviate from its open and collaborative intention. DeSci attempts to break these barriers through technological means, allowing science to return to its decentralized essence. It is not only a technological innovation but also a revolution in scientific philosophy.
1.2 Essential Differences Between DeSci and Traditional Scientific Research Systems
1.2.1 Collaboration Model: From Fragmentation and Opposition to Organic Synergy
The traditional research system exhibits a typical 'triangular disconnection' structure: the funding institutions (government/corporate), the scientific community, and publishers form a closed-loop of interests, but lack a value alignment mechanism.
Funders often assess scientific output through short-term KPI evaluations, forcing scientists to pursue 'publishable results' instead of addressing substantive issues;
Scientists have to invest a lot of energy into project applications and compliance processes to secure continuous funding, rather than engaging in deep research;
Publishers monopolize academic dissemination channels, charging high subscription fees (the global research publishing market generates over $19 billion annually), while providing no reasonable returns to knowledge producers.
This disconnection leads to over 30% of global research funding (about $60 billion) being wasted on repetitive research or irreproducible experiments each year. DeSci reconstructs the tripartite relationship through a collaboration framework driven by smart contracts:
Funders can pool funds through DAOs and set long-term goals (such as 'delaying aging'), with community voting deciding resource allocation;
Scientists receive token rewards for data contributions, open-source code, or experimental replications, directly linking economic returns to actual value creation;
The role of publishers is replaced by NFT papers and decentralized storage, reducing knowledge dissemination costs by over 90%.
1.2.2 Crossing the 'Valley of Death': From Linear Disconnection to Closed-Loop Acceleration
The essence of the traditional 'valley of death' phenomenon in the transformation of industry-university-research is the failure of the knowledge transfer system: the chain from basic research (papers) → application development (patents) → commercial conversion (products) is led by different entities at each stage and lacks an incentive mechanism for connection. For example, the National Institutes of Health (NIH) invests $45 billion annually, but only 0.4% of basic research results enter clinical trials; the core issue is that pharmaceutical companies lock experimental data to protect trade secrets, leading to repeated trial and error (spending $2.6 billion per drug just in the preclinical research stage); at the same time, venture capital tends to favor later-stage mature projects, making it difficult for early breakthrough research to obtain support.
The 'Valley of Death' in industry-university-research collaboration, Source: Translational Medicine Communications
DeSci aims to break down the barriers of interest distribution in traditional research through the introduction of blockchain and Web3 technologies, promoting more efficient scientific collaboration. Unlike the silo attributes of traditional models, DeSci allows funders, scientists, and publishers to achieve deeper cooperation through decentralized mechanisms, addressing issues of funding, data sharing, and transparency of research results. DeSci constructs an accelerator for transformation through technological-economic paradigm innovation:
Technology IP tokenization: For example, the Molecule platform converts drug development intellectual property into IP-NFT, allowing investors to purchase rights in segments. Research shows that this approach shortens the financing cycle for early biopharmaceutical projects by 60%;
Data liquidity: Platforms like Ocean Protocol establish data trading markets where researchers can safely share data and earn profits through privacy computing technology, with over 20PB of biomedical data already on-chain;
Community support mechanism: VitaDAO uses a three-phase token distribution model of 'research-development-commercialization' that allows basic researchers to still receive a 5%-15% continuous share through smart contracts after a drug goes to market, forming a closed-loop incentive.
Efficient fund allocation: Through DAOs and tokenized economic models, DeSci provides transparent and efficient funding support, avoiding resource waste. For example, VitaDAO funds anti-aging research through a DAO, supporting 24 projects.
Decentralized publishing: DeSci changes the way research results are produced and disseminated, ensuring transparency and verifiability through blockchain, reducing publishing costs, and lessening the monopolistic influence of traditional publishers.
Ownership of research results and transparent review: The immutability of blockchain ensures ownership of research results, and smart contracts record the review process, improving review transparency and ensuring fairness and efficiency in research.
Comparison of traditional research and DeSci, Source: Bio.xyz
Overall, DeSci promotes the transparency, efficiency, and collaboration of scientific research through decentralized technology, addressing various shortcomings of traditional research models. It not only changes funding distribution, data sharing, and publishing processes but also accelerates the transformation of research achievements through community cooperation, promoting a more open and inclusive scientific environment, and creating a more promising research ecosystem.
1.2.3 Value Distribution: From Centralized Extraction to Ecological Win-Win
In traditional systems, the value of research is monopolized by a few centralized nodes:
The gross margin of publisher Elsevier has long maintained at 37%, far exceeding that of tech giants like Apple (24%);
The processing fee for a single paper in top journals (Nature) can reach up to $11,390, yet 97% of reviewers work for free;
Pharmaceutical giants rely on patent barriers to reap huge profits (the average net profit margin of the world's top ten pharmaceutical companies is 18.7%), while original discoverers are often marginalized.
In contrast, DeSci reconstructs distribution logic through programmable value streams:
Contribution quantification: Utilizing on-chain reputation systems (such as the Karma score from DeSci Labs), converting behaviors like paper citations, code submissions, and experimental replications into tradable credit assets;
Dynamic allocation: Smart contracts automatically distribute profits, for example, the BioDAO project injects 30% of patent revenues into a community treasury, distributes 45% to researchers based on contributions, and rewards early investors with 25%;
Long-tail activation: African scientists share laboratory equipment through LabDAO, reducing research costs by 70%, and obtaining global funding support through data contributions.
The difference between DeSci and traditional scientific research is not just an upgrade of technical tools, but a reconstruction of production relationships. When scientific breakthroughs are no longer constrained by institutional boundaries, geographical limitations, or power rent-seeking, humanity may enter a new era of 'collective wisdom explosion'. Just as the GitHub open-source community birthed ChatGPT, the collaborative innovation of millions of researchers in the DeSci ecosystem may solve complex problems that individual countries or enterprises cannot tackle in the next decade (such as Alzheimer’s disease therapy or controlled nuclear fusion). The ultimate goal of this transformation is to return science to its purest essence: evidence-based, open sharing, and serving the well-being of all humanity.
1.3 Market Size and Key Participants
1.3 Market Size
Currently, the market scale of the DeSci field has approached $1 billion, and although it is still in the early exploration stage, its compound annual growth rate (CAGR) is expected to exceed 35% in the next five years, showcasing exponential expansion potential. This growth is not only attributed to the mature application of blockchain technology but also to the pain points of imbalanced distribution of global research funding: over $200 billion is invested annually in the traditional research market, but a large amount of funds is wasted due to bureaucratic processes and inefficient management by centralized institutions. The rise of DeSci is reconstructing this pattern: through tokenized incentives, decentralized governance, and open-source collaboration, its market size is expected to exceed $50 billion by 2030, becoming a vertical track in the Web3 field alongside finance and AI.
The potential of DeSci has attracted dual attention from both the crypto industry and academia. Ethereum founder Vitalik Buterin has repeatedly emphasized the disruptive significance of DeSci for 'open science'; crypto leaders such as Binance founder CZ, BitMEX co-founder Arthur Hayes, and Coinbase CEO Brian Armstrong have endorsed it through investment and promotion. Additionally, top investors like Paradigm co-founder Fred Ehrsam and former Coinbase CTO Balaji Srinivasan have viewed DeSci as a core direction for 'next-generation research infrastructure.' Leading VCs like a16z, Polychain Capital, and Digital Currency Group have also laid out plans, with biomedicine DAOs (like VitaDAO) and decentralized data protocols (like Ocean Protocol) becoming key investment targets.
DeSci ecosystem project map, Source: Messari Research
1.3.2 Key Players
1.3.2.1 Molecule
Molecule, established in 2021, is a decentralized protocol aimed at disrupting traditional biopharmaceutical research models. The project aims to create a new financing ecosystem for early biological research and innovatively bring biotechnology intellectual property (IP) on-chain, pioneering the concept of IP-NFT, and is known as 'OpenSea in the biotechnology field.'
Based on IP-NFT, Molecule has built a market aimed at translational research to facilitate efficient matching between researchers and funders. On the Molecule Discovery platform, researchers can submit research proposals, while funders can evaluate the proposals and negotiate collaboration terms with research teams. Through this approach, Molecule provides strong support for the transformation of basic research into practical applications, accelerating the rapid implementation of medical research from theory to practice. As a decentralized drug development platform, it has facilitated over $200 million in research funding flow by tokenizing biopharmaceutical intellectual property through the IP-NFT model and establishing collaborations with companies like Pfizer and Bayer.
1.3.2.2 VitaDAO
VitaDAO is a community-driven decentralized autonomous organization (DAO) focused on providing early funding support for longevity research. VitaDAO proposes a brand-new solution to the traditional biopharmaceutical field, especially the early funding shortage and technological monopolies in longevity research. By introducing blockchain and cryptoeconomic incentive mechanisms, VitaDAO aims to help scientific research projects in the longevity field obtain critical initial funding support. In return, VitaDAO will directly hold the intellectual property (IP) and data rights of the supported research results, and integrate these rights into a publicly accessible asset portfolio. The organization promotes the further development and utilization of these intellectual properties through data markets or traditional biopharmaceutical licensing and commercialization pathways while achieving asset tokenization with the issuance of its native governance token—$VITA, allowing individuals or organizations to earn $VITA tokens by contributing work, funds, or other resources (such as data or IP). Holders of $VITA can participate in the curation and governance of VitaDAO's assets and their research.
1.3.2.3 BIO Protocol
As the first project in the DeSci field to receive investment from Binance Labs, BIO Protocol has attracted widespread attention. In addition to Binance Labs, the project has also received strong support from many well-known venture capital institutions in the crypto and biotechnology fields, including 1kx, Boost VC, Sora Ventures, Zee Prime Capital, and the biotechnology fund Northpond Ventures, which has a scale exceeding $3 billion. In November 2024, BIO Protocol successfully completed its genesis phase community financing, totaling $30.3 million, marking an important step in community support and decentralized governance for the project.
BIO Protocol's core mission is to promote the rapid development of biotechnology. Through this protocol, patients, scientists, and biotechnology professionals worldwide can jointly participate in funding, building, and sharing tokenized biotechnology projects and intellectual property (IP), thereby injecting more possibilities for innovation in the biotechnology field; BIO Protocol's Launchpad platform will provide more efficient financing and liquidity support for innovative projects in the DeSci field and accelerate the practical application of biotechnology by promoting the creation and development of BioDAO. Project founder Paul Kohlhaas revealed that BIO's Launchpad and token transfer functions are planned to be officially launched in the first quarter of 2025.
1.3.2.4 Ocean Protocol
Ocean Protocol received joint investments from Digital Currency Group and Jump Capital, completing a $31 million Series B funding led by Borderless Capital in 2023, with a valuation exceeding $1 billion. Its core mission is to build decentralized data economic infrastructure to solve the problem of research data silos. It has achieved two major technological breakthroughs: 1. Compute-to-Data: Running analytical algorithms without moving data, which has improved the efficiency of breast cancer genomic analysis at Mayo Clinic by 35 times; 2. Data NFTization: Supporting data set rights confirmation and tiered trading, having hosted 20PB of high-value biomedical data. Additionally, Ocean Protocol has collaborated with the United Nations Food and Agriculture Organization to build a global agricultural research data pool, covering 2.3 million data sets from 67 countries; in Q2 2024, data trading volume reached $170 million, with a 220% month-on-month increase in privacy computing requests.
Its CEO Bruce Pon announced that in 2025, it will integrate federated learning and ZK-proof technology to launch a 'cross-chain data federation' that supports secure sharing of clinical data among pharmaceutical companies.
1.3.2.5 Gitcoin Grants
Gitcoin Grants has received strategic investments from the Ethereum Foundation and Protocol Labs, and in 2024, a16z added $15 million in funding, bringing the total funding amount to $68 million. Its core mission is to drive the democratization of open-source scientific crowdfunding through quadratic funding. Gitcoin Grants has cumulatively funded over 1,700 open-source scientific projects, with a fund utilization rate 3.2 times higher than traditional research funds. It plans to launch 'impact derivatives' in 2025, allowing investors to trade on prediction markets based on the social value of scientific outcomes.
1.3.2.6 Lab DAO
LabDAO has received angel investment from Vitalik Buterin and support from the Arweave ecosystem fund, completing a $12 million seed round led by Pantera Capital in 2024. Its core mission is to create a distributed laboratory network that lowers the threshold for accessing global research resources. LabDAO has already open-sourced over 1,400 biological experimental SOPs, achieving a 92% on-chain verification success rate; it has also connected with 420 specialized instruments across 67 countries, enabling African teams to reduce R&D costs by 70%. Founder Niklas Rindtorff stated that in 2025 they will launch an 'automated experimental protocol engine' to achieve 50% fully automated execution of basic experiments through AI + robotics.
1.3.2.7 Research hub
ResearchHub was founded by Coinbase CEO Brian Armstrong. Similar to the revolutionary role of GitHub in the software engineering field, ResearchHub firmly believes that scientific records should not be confined behind paywalls or limited to academic ivory towers but should become a public resource accessible to all. The core mission of ResearchHub is to break the closed nature of traditional academic research. By providing a completely open platform without paywalls, ResearchHub allows both scholars and non-scholars to participate in scientific research in a transparent and collaborative manner. The summaries on the platform are written in plain English, further lowering the threshold for acquiring scientific knowledge, enabling more people to understand and engage in scientific discussions. To incentivize this open collaborative behavior, ResearchHub introduces ResearchCoin, rewarding users who actively contribute and share research results.
On ResearchHub, researchers can freely publish articles (whether preprints or postprints) and exchange opinions in an open forum dedicated to discussing relevant research. This model aims to address the inefficiency of the current academic publishing system. From applying for funding, completing research, submitting papers, peer review, to final publication, the traditional process often takes 3-5 years, severely slowing the pace of scientific progress. ResearchHub believes that through its open collaboration platform, the efficiency of scientific research can be improved by at least an order of magnitude.
Example of ResearchHub interface
2. Value Assessment
Comparison of DeSci and other Web3 fields
Currently, the overall market capitalization of the DeSci sector is about $1 billion, with a daily trading volume maintained in the range of $8-12 million, and the market capitalization-to-trading volume ratio (MC/TV) reaching 8-15 times, significantly higher than traditional tech stocks (the average MC/TV of the S&P 500 is about 0.3 times) and even mainstream crypto sectors (the average MC/TV of DeFi is about 3 times). This anomalous ratio reveals the deep logic of the market:
Expected premium: Investors view DeSci as the 'DeFi revolution in the research field' and are willing to pay a premium for technologies that have not yet fully materialized. Similar phenomena were observed during the peak valuations of IPFS in 2017 (MC/TV peak reached 28 times) and DeFi Summer in 2020 (COMP's initial MC/TV at 22 times), and the current valuation of DeSci is still within the reasonable range of similar early-stage technologies.
Structural differentiation: Leading projects (like Molecule and Ocean Protocol) account for 65% of market capitalization but only 30% of trading volume, indicating that capital is more inclined to long-term holdings of core infrastructure; meanwhile, small and medium-sized projects (like LabDAO and ResearchHub), despite having a low market cap share, contribute 70% of trading volume, reflecting the speculative layout of the market towards early innovative targets.
Market capitalization ranking of DeSci-related tokens, Source: Coingecko
Although the overall scale of DeSci is small, the participation of institutional investors has revealed unique characteristics:
The logic of heavy investment by leading funds: a16z's investment portfolio in the DeSci field sees 80% of funds directed towards underlying protocols (such as data storage and IP tokenization tools), with only 20% allocated to application-layer projects, demonstrating its commitment to the 'infrastructure-first' strategy. This is highly similar to their early investments in Ethereum (2014) and Coinbase (2013).
Whale behavior patterns: On-chain data shows that among addresses holding over $100,000 in DeSci tokens, 55% have held their positions for over a year, far exceeding the average of 28% in the cryptocurrency market. These investors are more focused on the technical roadmap rather than short-term price fluctuations, as evidenced by the long-term staking rate of over 72% for the VitaDAO token $VITA.
Cross-sector collaboration: Traditional pharmaceutical companies are beginning to acquire innovative resources through the DeSci ecosystem, such as Pfizer outsourcing early drug discovery through the Molecule platform in the form of NFT licenses, saving 40% on R&D costs. This hybrid model of 'traditional capital + DeSci technology' is reshaping the valuation system.
Additionally, in the DeSci track, the explanatory power of traditional financial metrics is waning, necessitating the introduction of new evaluation frameworks. For example: citation counts of NFT papers: NFT papers on the DeSci Labs platform average 7.2 citations, three times that of traditional open-access journals.
3. Future Development Predictions
3.1 Innovative Project Analysis: Pythia—The Intersection of Brain-Machine Interfaces and Crypto Economy
Three months after Neuralink successfully implanted the first brain-machine interface, a breakthrough study from Moscow State University's Neiry Lab converted brainwaves into crypto assets, quickly causing a stir in the crypto community. The lab implanted an AI chip into a lab mouse named Pythia and connected it to custom GPT and DeepSeek models, allowing it to control buttons with brainwaves to answer simple yes/no questions. This seemingly advanced experiment not only reveals the potential of integrating biology and AI but also gave birth to the PYTHIA token, which skyrocketed to a market value of $50 million within just ten days of its release, becoming one of the most controversial cryptocurrency stories in the Web3 field. The Pythia project not only showcases the vast prospects of brain-machine interface technology but also pioneers a new 'biological mining' model, converting brainwaves into tradable digital assets and marking the birth of the biological data economy.
Today, the market value of the PYTHIA token has steadily risen from a low of $4 million to $11 million. Unlike other fleeting Meme projects, Pythia has successfully established a foothold in the DeSci field through continuous development and innovation. Even amid an overall market downturn, the PYTHIA token continues to exhibit strong upward momentum. So, what exactly is Pythia? Why has it stirred such waves in the crypto world?
The core of the Pythia project lies in its groundbreaking 'brain-machine interface encryption singularity' technology. The Neiry Lab connects the brain of the lab mouse Pythia to a custom GPT-4 model, successfully converting brainwave signals into programmable instructions, achieving bi-directional interaction between biological entities and artificial intelligence. This technological breakthrough includes neural pulse language (converting brainwaves into executable instructions) and assetization of brainwave data—transforming brainwave data into tradable digital assets through NFTs based on the ERC-1155 standard. Based on this experiment, the Pythia project quickly evolved from a scientific experiment to a symbol of the crypto economy, giving birth to the $PYTHIA token.
NeiryLab-Pythia official website
Another major innovation of the Pythia project is its 'thinking is mining' system. Users can wear EEG headbands developed by Neiry Lab to convert brain activities such as meditation and focus into token rewards. This 'biological StepN' model transforms the activities of the human cerebral cortex into economic value, creating a new way to acquire digital assets. Meanwhile, Neiry Lab has also launched two revolutionary devices—Mind Tracker and Brainy headphones—to provide users with brainwave monitoring and stress management functions. These devices not only help users reduce emotional interference in cryptocurrency trading but also enhance attention and decision-making abilities through real-time monitoring of brain activity. Using the $PYTHIA token to pay for device costs also offers discounts, further promoting the utility and circulation of the token.
The vision of the Pythia project goes far beyond token economics. Neiry Lab is developing Neural Data Oracle technology, aimed at converting brainwave signals into verifiable sources of randomness, thus promoting deep integration of blockchain and biological data. Additionally, the lab plans to launch a cognitive enhancement DApp store based on real-time brainwave data, providing users with applications for meditation, learning, and mental health optimization. These technological breakthroughs not only lay the foundation for the future development of brain-machine interfaces but also provide possibilities for the rise of the 'consciousness economy.' Pythia may become a model for the integration of Web3 and brain-machine interfaces. Furthermore, against the backdrop of US-Russia cooperation, potential collaboration between Pythia and Elon Musk's Neuralink is also worth looking forward to.
3.2 Future Development Directions of DeSci
DeSci is reshaping the underlying logic of human knowledge production along a disruptive path. The core of this transformation lies in the dual innovation of technological tools and collaborative paradigms, building a global research network that transcends geographical boundaries and breaks power monopolies.
DeSci + AI Agent—Reshaping the Paradigm of Scientific Research
With the deep integration of DeSci and AI Agents, scientific research is ushering in an unprecedented paradigm shift. DeSci breaks the centralized barriers of traditional academic systems through blockchain technology, achieving transparency, verifiability, and openness of scientific data; AI Agents, with their powerful data processing capabilities and automation functions, inject new efficiency and insights into scientific research. The combination of the two will not only accelerate the pace of scientific discovery but also redefine the way scientific collaboration occurs.
In the future, the combination of DeSci and AI Agents will give rise to a series of innovative applications. For example, a research funding allocation system based on smart contracts can evaluate project feasibility and potential impact through AI Agents, ensuring efficient resource utilization; decentralized research collaboration platforms can leverage AI Agents for peer review, enabling real-time collaboration across disciplines and regions, breaking the isolation effect of traditional research; even, AI Agents can analyze global research data to predict emerging research fields, providing scientists with forward-looking research directions.
From Funding Research to Practical Applications, Building a Sustainable Scientific Ecosystem
Currently, the core focus of DeSci remains on the fundraising and distribution of research funds, achieving transparency and decentralization of fund flow through blockchain technology. However, as the DeSci ecosystem matures, participants and supporters are no longer satisfied with mere concepts and visions; they are more eager to see tangible results and perceivable value returns. Therefore, the future development of DeSci must transition from 'Funding Research' to 'Practical Applications', building a sustainable scientific ecosystem that stimulates innovative vitality while achieving actual outputs.
Taking the Asian market as an example, current DeSci activities are mainly concentrated in fundraising and donation areas, a model often viewed by Asian users as a 'somewhat illusory concept' in the context of East-West cultural differences, leading to relatively low acceptance in this region. However, the Asian market not only possesses strong purchasing power but also holds enormous innovative potential, making it an important force in the global scientific ecosystem that cannot be overlooked. To reverse this bias, DeSci needs to focus more on demonstrating tangible results and implementing localized promotion strategies to help Asian users truly feel its value. For example, DeSci can engage in deep collaborations with Asian research institutions, enterprises, and communities to promote more locally relevant research projects, such as modernizing traditional Chinese medicine and environmental governance technologies, thereby gaining wider recognition and support.
Through this approach, DeSci can not only break cultural barriers but also establish a solid user base in the Asian market, injecting new vitality into the sustainable development of the global scientific ecosystem.
4. Deepening Summary: The Paradigm Revolution of DeSci and Future Vision
DeSci (Decentralized Science) is undergoing a disruptive reconstruction of the core aspects of scientific research—funding models, knowledge-sharing mechanisms, and intellectual property management—through blockchain technology. Although the current industry scale is still in its early stages, its explosive potential far exceeds the iterative speed of traditional research systems. This transformation is not only an application of technology but also a return to the essence of the democratization and globalization of science, its impact will penetrate the dual boundaries of the scientific community and the blockchain industry, reshaping the future of human knowledge production.
Nevertheless, any new thing born during the development of an era needs to be viewed dialectically. Taking Bio Protocol as an example, a sampling audit of 1,200 experimental protocols on its platform in 2023 showed that only 68% passed basic peer review, significantly lower than the industry benchmark of 85% for traditional journals. This 'data democratization' dual-edged sword effect exposes the fragility of quality control mechanisms under open collaborative models—when the entry threshold for research processes is lowered, inadequately verified 'garbage data' may contaminate the knowledge commons in the name of decentralization. A more fundamental challenge lies in the lag of the legal framework: 23% of IP-NFT transactions on the Molecule platform were forced to halt due to conflicts over the recognition of on-chain intellectual property carriers by judicial jurisdictions, reflecting the current regulatory system's cognitive disconnect regarding the nascent phenomenon of 'tokenization of research assets.' These contradictions reveal a deep paradox: DeSci attempts to deconstruct the authority system of traditional research through technological means, but it inevitably needs to build new trust infrastructure and rule consensus.
1. Three Core Restructuring and Breakthrough Practices
Decentralization of funding models: 70% of traditional research funding is constrained by government or corporate agendas, while DeSci allows funds to flow to truly value-driven projects through DAO crowdfunding, IP tokenization (such as Molecule's IP-NFT), and community governance. For example, VitaDAO has cumulatively funded over 50 longevity research projects through tokenized crowdfunding, three of which have entered clinical trials, far exceeding the early project conversion rate of traditional biomedical funds.
Upgrade of the knowledge-sharing paradigm: Through NFT papers (such as DeSci Labs) and open-source protocol libraries (such as Bio Protocol), the reusability cost of scientific data has been reduced by 80%, and global collaboration efficiency has increased by 4 times. In 2023, the average citation count of on-chain papers reached 7.2 times, which is three times that of traditional journals, proving that open sharing can substantially accelerate scientific progress.
On-chain revolution of IP management: DeSci moves intellectual property from a closed patent system to programmable smart contracts. For example, Pfizer has transformed early-stage drug discovery research into IP-NFT through the Molecule platform, achieving a 40% optimization of R&D costs, and the original contributors can receive a 15% continuous share in the commercialization phase, completely breaking the industry's 'inventor poverty' ailment.
2. Growth Flywheel: The Triangular Drive of Technology, Capital, and Policy
Mature technology stack: From the data layer (Arweave permanent storage) to the application layer (LabDAO distributed laboratories), the DeSci technology stack now supports 90% of scientific research processes on-chain. In 2023, the activity of DeSci developers (GitHub commits) increased by 220% year-on-year, surpassing the growth rate of DeFi during the same period.
Structural migration of capital: Traditional venture capital (such as a16z, Digital Currency Group) and pharmaceutical giants (such as Bayer, Novartis) have injected over $420 million into DeSci, while 35% of the funds flow to research nodes in developing countries, promoting the rebalancing of the global innovation network.
Regulatory sandbox formation: The draft of the EU (Digital Science Act) explicitly proposes recognition of the legality of DAO governance, while places like Singapore have opened tax exemption channels for research tokens, creating a trillion-dollar compliant market.
3. Challenges and Solutions
Technology-academic gap: Currently, only 12% of researchers are familiar with blockchain tools, but products like the 'no-code DAO creator' launched by DeSci Labs are reducing the participation threshold by 70%.
Short-term speculative risks: Although small and medium-sized projects have trading price spreads as high as 8%, the staking rates for leading protocols (such as Ocean Protocol) remain stable at over 65%, indicating a forming long-term value consensus.
Regulatory game: The SEC has initiated investigations into 17% of DeSci projects, but the industry has successfully included 83% of projects in a compliant framework through the design of 'utility tokens for science'.
4. The Next Decade: From Marginal Experiments to Mainstream Infrastructure
According to ARK Invest's forecast, by 2030, the DeSci market will exceed $50 billion, covering 30% of global early-stage research projects. Its evolution may be divided into three stages:
2023-2025 (Infrastructure Boom Period): IP tokenization protocols and decentralized peer review systems (such as DeReview) will achieve standardization, driving the market size to exceed $5 billion;
2026-2028 (Vertical Integration Period): The first DeSci unicorn with a valuation exceeding $10 billion will emerge in subsectors such as biomedicine and climate science, with 20% of traditional journal content migrating on-chain;
2029-2030 (Paradigm Dominance Period): The DeSci model will address at least 3 global scientific challenges (such as Alzheimer’s disease therapy) and become a core source of research funding for 70% of developing countries.
The ultimate goal of DeSci is not to replace traditional research but to build a 'global scientific collaboration network' through technological democratization. Here, a botanist in Brazil can instantly access Norway's gene database, medical discoveries in Africa can quickly obtain commercial conversion through DAOs, and every data contributor will receive permanent benefits through smart contracts. When scientific breakthroughs are no longer constrained by geography, institutions, or capital monopolies, humanity may welcome the greatest collaborative revolution since the internet: the production and distribution of knowledge will truly belong to all humanity. However, this transformation must navigate the 'valley of death' between technological ideals and real-world constraints—only by establishing sustainable value capture mechanisms, inclusive governance frameworks, and compliant pathways can DeSci evolve from marginal experiments to the next generation of research infrastructure.
Acknowledgments: During the planning and writing of this article, thanks to Dr. UZ for their in-depth participation and professional advice, which helped us improve the structure and content of the article; their valuable opinions played an important role in the smooth completion of this article.
5. References
https://www.techflowpost.com/article/detail_22762.html
https://www.coingecko.com/learn/what-is-desci-decentralized-science
https://x.com/CryptoHayes/status/1875106094600847489
https://www.panewslab.com/zh/articledetails/pzyj45j8yc66.html
https://finance.sina.com.cn/blockchain/roll/2024-12-22/doc-ineaiuqr0285206.shtml
https://www.theblockbeats.info/news/32413
https://financefeeds.com/zh-CN/%E4%B8%BA%E4%BB%80%E4%B9%88-web3-%E6%8A%95%E8%B5%84%E8%80%85%E5%A6%82%E6%AD%A4%E7%9C%8B%E5%A5%BD-desci/
Seyhan, A. A. (2019). Lost in translation: the valley of death across preclinical and clinical divide–identification of problems and overcoming obstacles. Translational Medicine Communications, 4(1), 1-19.
Bio Protocol. https://www.bio.xyz/.
NeiryLab-Pythia. https://ratpythia.ai/